Evidence map›Paper›PMID 37630394›Full record

ArticleMolecules (Basel, Switzerland)2023

Murat Zh Zhurinov, Alfira F Miftakhova, Viktoriya Keyer, Zarina T Shulgau, Elena V Solodova, Maxat K Kalykberdiyev, Arlan Z Abilmagzhanov, Eldar T Talgatov, Sauyk Ait, Alexandr V Shustov

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Murat Zh Zhurinov"D.V. Sokolskiy Institute of Fuel, Catalysis and Electrochemistry" JSC, Almaty 050010, Kazakhstan.
Alfira F Miftakhova"D.V. Sokolskiy Institute of Fuel, Catalysis and Electrochemistry" JSC, Almaty 050010, Kazakhstan.
Viktoriya KeyerLaboratory for Genetic Engineering, RSE "National Center for Biotechnology", Astana 010000, Kazakhstan.
Zarina T ShulgauLaboratory for Genetic Engineering, RSE "National Center for Biotechnology", Astana 010000, Kazakhstan.ORCID 0000-0001-8148-0816
Elena V Solodova"D.V. Sokolskiy Institute of Fuel, Catalysis and Electrochemistry" JSC, Almaty 050010, Kazakhstan.
Maxat K Kalykberdiyev"D.V. Sokolskiy Institute of Fuel, Catalysis and Electrochemistry" JSC, Almaty 050010, Kazakhstan.ORCID 0000-0002-4309-441X
Arlan Z Abilmagzhanov"D.V. Sokolskiy Institute of Fuel, Catalysis and Electrochemistry" JSC, Almaty 050010, Kazakhstan.
Eldar T Talgatov"D.V. Sokolskiy Institute of Fuel, Catalysis and Electrochemistry" JSC, Almaty 050010, Kazakhstan.ORCID 0000-0001-8153-4765
Sauyk Ait"D.V. Sokolskiy Institute of Fuel, Catalysis and Electrochemistry" JSC, Almaty 050010, Kazakhstan.
Alexandr V ShustovLaboratory for Genetic Engineering, RSE "National Center for Biotechnology", Astana 010000, Kazakhstan.ORCID 0000-0001-9880-9382
National Center for Biotechnology · KZAl-Farabi Kazakh National University · KZ

Funding

Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan BR10965271
6 · The paper itself

Abstract

In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2 virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity of drugs that were available in Kazakhstan during the acute phase of the epidemic against SARS-CoV-2. Antiviral activity is reported for Favipiravir, Tilorone, and Cridanimod, which are registered drugs used for the treatment of respiratory viral infections in Kazakhstan. A licorice (

Indexed as

COVID-19GlycyrrhizaAmidesAnimalsAntiviral AgentsPlant ExtractsPyrazinesSARS-CoV-2TiloroneAmidesAntiviral AgentsfavipiravirGlycyrrhiza glabra extractPlant ExtractsPyrazinesTiloroneantiviralsCOVID-19CridanimodFavipiravirGlycyrrhiza glabraGlycyrrhizininfluenza viruslicoricephytochemicalsSARS-CoV-2 virusTilorone

Identifiers

PMID37630394
PMCPMC10458004
OpenAlexW4386029042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.